4.36
Precision Biosciences Inc stock is traded at $4.36, with a volume of 414.91K.
It is up +3.56% in the last 24 hours and down -13.15% over the past month.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
See More
Previous Close:
$4.21
Open:
$4.27
24h Volume:
414.91K
Relative Volume:
1.99
Market Cap:
$104.95M
Revenue:
$52.29M
Net Income/Loss:
$-73.52M
P/E Ratio:
-6.6061
EPS:
-0.66
Net Cash Flow:
$-100.45M
1W Performance:
+4.81%
1M Performance:
-13.15%
6M Performance:
+1.16%
1Y Performance:
-8.98%
Precision Biosciences Inc Stock (DTIL) Company Profile
Name
Precision Biosciences Inc
Sector
Industry
Phone
919-314-5512
Address
302 EAST PETTIGREW STREET, DURHAM, NC
Compare DTIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DTIL
Precision Biosciences Inc
|
4.36 | 101.34M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-30-24 | Initiated | Guggenheim | Buy |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Jun-09-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-27-20 | Resumed | BTIG Research | Buy |
| Apr-03-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-05-20 | Initiated | Stifel | Buy |
| Feb-25-20 | Initiated | William Blair | Outperform |
| Aug-09-19 | Initiated | BTIG Research | Buy |
| Jul-16-19 | Initiated | H.C. Wainwright | Buy |
| Apr-22-19 | Initiated | Barclays | Overweight |
| Apr-22-19 | Initiated | Goldman | Buy |
| Apr-22-19 | Initiated | JP Morgan | Overweight |
| Apr-22-19 | Initiated | Jefferies | Buy |
View All
Precision Biosciences Inc Stock (DTIL) Latest News
Precision BioSciences: Tiny Gene-Editing Stock Caught Between Deep Cuts and Big Optionality - AD HOC NEWS
Precision Bio's DMD Therapy Gets Rare Pediatric Status, But Stock Slides; Retail Crowd Sees ‘Good Risk-Reward’ - MSN
What drives Precision BioSciences Inc PBS0 stock priceSell Signals and Alerts & Low Cost Portfolio Tips - earlytimes.in
Sterling Tools Limited Ranks High in Smart Money TrackerFundamental Strength Indicators & Explosive Profit Growth - earlytimes.in
Aug Ideas: Is Precision BioSciences Inc stock a top pick in earnings season - moha.gov.vn
Short Interest in Precision BioSciences, Inc. (NASDAQ:DTIL) Expands By 27.4% - MarketBeat
Precision Biosciences Inc files for mixed shelf of up to $250 millionSEC filing - MarketScreener
Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - Seeking Alpha
Will Precision BioSciences Inc. stock benefit from infrastructure spendingMarket Breadth Indicators & Investor Community Interactions - bollywoodhelpline.com
Can Precision BioSciences Inc. stock maintain operating marginsEarnings Volatility Patterns & Affordable Stock Picks - bollywoodhelpline.com
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - 01net
What analysts say about Precision BioSciences Inc PBS0 stockInstitutional Buying Trends & Free Explosive Trading Growth - earlytimes.in
Precision BioSciences Earnings Notes - Trefis
Will Precision BioSciences Inc. stock gain from government policies2025 Price Targets & Free Safe Capital Growth Stock Tips - Улправда
Is Precision BioSciences Inc. (PBS0) stock a top hedge fund pickWeekly Profit Recap & Safe Investment Capital Preservation Plans - Улправда
Can Precision BioSciences Inc. stock reach $100 price targetJuly 2025 Sentiment & Community Trade Idea Sharing Platform - Bölüm Sonu Canavarı
How Precision BioSciences Inc. stock compares to industry benchmarksWeekly Investment Summary & Weekly Watchlist for Consistent Profits - Улправда
How Precision BioSciences Inc. stock reacts to global recession fearsNew Guidance & Technical Pattern Based Buy Signals - DonanımHaber
Market Recap: How Precision BioSciences Inc. stock reacts to global recession fears2025 Price Targets & Scalable Portfolio Growth Methods - DonanımHaber
How Precision BioSciences Inc. stock compares to market leadersJuly 2025 Drop Watch & Consistent Profit Trading Strategies - DonanımHaber
Will Precision BioSciences Inc. stock outperform Nasdaq indexIPO Watch & Daily Oversold Bounce Ideas - Улправда
Aug Shorts: Will Precision BioSciences Inc. stock benefit from infrastructure spendingPortfolio Update Report & Free Technical Pattern Based Buy Signals - Улправда
Street Watch: Is Precision BioSciences Inc. (PBS0) stock a top hedge fund pick2025 Key Highlights & Daily Profit Maximizing Tips - ulpravda.ru
Precision BioSciences (NASDAQ:DTIL) Director Geno Germano Buys 3,000 Shares - MarketBeat
Insider Buying: Stanley Frankel Acquires Additional Shares of Pr - GuruFocus
Insider Buying: Precision BioSciences (NASDAQ:DTIL) Director Acquires $12,690.00 in Stock - MarketBeat
Dir Germano Buys 3,000 ($14.2K) Of Precision BioSciences Inc [DTIL] - TradingView — Track All Markets
Dir Brown Buys 1,381 ($6.9K) Of Precision BioSciences Inc [DTIL] - TradingView — Track All Markets
Precision Biosciences Executives Increase Holdings - TradingView — Track All Markets
Precision Biosciences (DTIL) director adds 3,000 shares in open-market buy - Stock Titan
Precision BioSciences (DTIL) director reports purchase of 2,700 shares - Stock Titan
Precision BioSciences (DTIL) director reports purchase of 1,381 shares - Stock Titan
Financial Analysis: Precision BioSciences (NASDAQ:DTIL) & Upstream Bio (NASDAQ:UPB) - Defense World
Precision BioSciences (DTIL) Receives a Rating Update from a Top Analyst - The Globe and Mail
Aug Summary: Can Precision BioSciences Inc stock hit analyst price targetsWeekly Trading Summary & Reliable Breakout Stock Forecasts - moha.gov.vn
Sidoti Events, LLC's Year-End Virtual Investor Conference - Yahoo Finance
Block Trades: Is Precision BioSciences Inc stock resilient to inflationBuy Signal & Comprehensive Market Scan Reports - BỘ NỘI VỤ
Precision BioSciences launches $75M stock and warrant offering - MSN
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), MBX Biosciences, Inc. (MBX) and Praxis Precision Medicines (PRAX) - The Globe and Mail
Is Precision BioSciences Inc. stock resilient to inflationJuly 2025 Decliners & Consistent Return Strategy Ideas - Newser
Can Precision BioSciences Inc. (PBS0) stock ride next bull market cycleWeekly Trading Summary & AI Enhanced Trading Signals - Newser
Precision Biosciences: Still Swinging And Finally Drawing Blood (NASDAQ:DTIL) - Seeking Alpha
Why Precision BioSciences Inc. (PBS0) stock is a strong buy callJuly 2025 Fed Impact & Growth Focused Entry Point Reports - Newser
How Precision BioSciences Inc. stock reacts to oil pricesQuarterly Profit Review & Reliable Breakout Forecasts - Newser
Is Precision BioSciences Inc. (PBS0) stock a contrarian opportunity - Newser
Precision BioSciences (DTIL) Stock Analysis Report | Financials & Insights - Benzinga
Will Precision BioSciences Inc. (PBS0) stock announce a stock split2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - Newser
How Precision BioSciences Inc. (PBS0) stock compares with market leaders2025 Top Gainers & High Accuracy Buy Signal Tips - Newser
Precision Biosciences Inc Stock (DTIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Precision Biosciences Inc Stock (DTIL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Frankel Stanley | Director |
Dec 16 '25 |
Buy |
4.70 |
2,700 |
12,690 |
19,478 |
| Brown Melinda | Director |
Dec 15 '25 |
Buy |
4.97 |
1,381 |
6,864 |
23,346 |
| Kelly John Alexander | Chief Financial Officer |
Nov 02 '25 |
Option Exercise |
0.00 |
3,605 |
0 |
78,601 |
| Kelly John Alexander | Chief Financial Officer |
Nov 03 '25 |
Sale |
6.49 |
1,303 |
8,456 |
77,298 |
| Scimeca Dario | General Counsel and Secretary |
Nov 02 '25 |
Option Exercise |
0.00 |
1,835 |
0 |
28,923 |
| Scimeca Dario | General Counsel and Secretary |
Nov 03 '25 |
Sale |
6.49 |
665 |
4,316 |
28,258 |
| Amoroso Michael | President and CEO |
Nov 02 '25 |
Option Exercise |
0.00 |
9,444 |
0 |
118,984 |
| Amoroso Michael | President and CEO |
Nov 03 '25 |
Sale |
6.49 |
3,409 |
22,124 |
115,575 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):